Three S&P/ASX 200 Index (ASX: XJO) healthcare stocks are well placed to outperform in 2025. Here’s what you need to know.

This ASX tech stock has delivered enormous returns in the past year. A leading fund manager thinks it can still deliver more ...

ASX exchange-traded funds (ETFs) continue to grow in popularity on the Australian share market. Here are some of the most ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...

The first full trading week of 2025 is ending on a high note for stockholders of two rocketing ASX small-cap shares. Here’s ...

Over the course of the 12 months, Zip's shares rallied a massive 363%. This made it the best performing stock on the ASX 200 ...

After being punished over the past 12 months, is now the time to pounce on ASX 200 mining shares? Let's dive in.

Knowing when to sell shares is more difficult than you might first think. Plenty of mistakes are made. Let's see when it's ...

The Novonix share price is now up approximately 15% since this time last year. Though, it remains down heavily on a two-year ...

These two S&P/ASX 300 Index (ASX: XKO) shares are highly rated by a leading fund manager. Here’s why these experts are ...

But after these rosy 2024 gains, many ASX investors might be looking for some stable, defensive investments to ride out 2025. After all, the returns of both the Australian and American markets were ...